AVEO PHARMACEUTICALS, INC retains the rights to commercialise ... Register now to create your own custom …
Carcinoma
AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO)‘s stock had its “outperform” rating restated by investment analysts at FBR & Co in a research report issued on Monday, April 17th. They currently have a $3.00 target price on the …
Breeze1mon
Chevrolet Aveo
Aveo Pharmaceuticals (Nasdaq: AVEO) saw its stock rise more than 13 percent on Thursday after the company announced its first profitable quarter, and the extension of a cancer drug trial that could mean that patients are living …
Visit us today and download our complete research report on ATNM for free at: http://stock
Research
Aveo Oncology (NASDAQ: AVEO) has seen its share of ups and downs over the past year as it has fought to prove the worth of its kidney cancer drug, tivozanib. Now the moment of truth is at hand, with an independent advisory panel …
BOSTON (MarketWatch) -- Shares of AVEO Pharmaceuticals AVEO, -3.88% plunged 10% to $17.13 in early action Wednesday after the biotech company priced a public stock offering below Tuesday's closing price. The company said …
Investors are looking closer at Aveo Pharmaceuticals Inc., in part because of the sale of Idenix Pharmaceuticals, the Boston Business Journal says. Aveo’s stock is up 37 percent since June 9 — the day Idenix said it would be bought …
March 28 Aveo Pharmaceuticals Inc: * Aveo announces proposed offering of common stock * Aveo Pharmaceuticals- offering's proceeds to be used in development, pre-commercial expenses incurred for ongoing phase …
News headlines about AVEO Pharmaceuticals (NASDAQ:AVEO) have been trending somewhat positive recently, Alpha …
Chevrolet Aveo